Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
4.750
+0.230 (5.09%)
At close: Feb 6, 2026, 4:00 PM EST
4.730
-0.020 (-0.42%)
After-hours: Feb 6, 2026, 5:45 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 116 employees as of December 31, 2024. The number of employees increased by 7 or 6.42% compared to the previous year.
Employees
116
Change (1Y)
7
Growth (1Y)
6.42%
Revenue / Employee
$222,672
Profits / Employee
-$556,379
Market Cap
224.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | 65 | 19 | 41.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 151 |
| Heron Therapeutics | 122 |
| MediWound | 111 |
| Orchestra BioMed Holdings | 70 |
| Shattuck Labs | 44 |
| Achieve Life Sciences | 25 |
| Climb Bio | 18 |
| Inhibikase Therapeutics | 16 |
SLN News
- 7 weeks ago - Silence Therapeutics Announces Leadership Changes - Business Wire
- 2 months ago - Silence Therapeutics: Divesiran Targets High-Burden PV - Seeking Alpha
- 3 months ago - Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Silence Therapeutics Completes Enrollment in SANRECO Phase 2 Study of Divesiran for Polycythemia Vera (PV) - Business Wire
- 5 months ago - Silence Therapeutics Plc (SLN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 months ago - Silence Therapeutics to Participate in September Investor Conferences - Business Wire
- 6 months ago - Silence Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Business Wire